Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Follow up of Patients After Oral Immunotherapy for Cow's Milk, Eggs and Peanuts
NCT01999387
Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety
NCT06256146
Oral Immunotherapy in Food Allergy in Finland
NCT02640014
Food Oral Immunotherapy for Peanut Allergy
NCT04222491
Single Center Food Allergy Oral Immunotherapy Study
NCT01490177
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The questionnaires will then be administered to patients and families undergoing food oral immunotherpy, before during and following treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children 8-12- control
Children aged 8-12 years with food allergy who are not undergoing oral immunoterapy
No interventions assigned to this group
Parents 0-12 - control
Parents to children aged 0-12 years with food allergy who are not undergoing oral immunoterapy
No interventions assigned to this group
Children 8-12 - OIT
Children aged 8-12 years with food allergy who are undergoing oral immunoterapy
Oral immunotherapy
Teenagers 13-17 - OIT
Teenagers aged 13-17 years with food allergy who are undergoing oral immunoterapy
Oral immunotherapy
Adults >18 - OIT
Adults\> 18 years with food allergy who are undergoing oral immunoterapy
Oral immunotherapy
Parents 0-12 - OIT
Parents to children aged 0-12 years with food allergy who are undergoing oral immunoterapy
Oral immunotherapy
Parents 13-17 - OIT
Parents to teenagers aged 13-17 years with food allergy who are undergoing oral immunoterapy
Oral immunotherapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral immunotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assaf-Harofeh Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asaf Harofeh Medical Center
Ẕerifin, Israel, Israel
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
52/14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.